ASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADOR
Release Date:
Drs. Jonathan Rosenberg and Alicia Morgans share their insights into some late-breaker abstracts presented at the 2024 ASCO GU symposium in San Francisco. The first is a subgroup analysis from EV‑302 with enfortumab vedotin and pembrolizumab, and the other is AMBASSADOR, which looks at adjuvant pembrolizumab in locally advanced and muscle invasive urothelial cancer.
ASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADOR